The Safety and Efficacy of Tenofovir DF in Combination with Lamivudine and Efavirenz Through 6 Years in Antiretroviral-Naïve HIV-1—Infected Patients-Reference-Cited by-同舟云学术

The Safety and Efficacy of Tenofovir DF in Combination with Lamivudine and Efavirenz Through 6 Years in Antiretroviral-Naïve HIV-1—Infected Patients

Published:2007-06-01 Issue:3 Volume:8 Page:164-172
ISSN:1528-4336
Container-title:HIV Clinical Trials
language:en
Short-container-title:HIV Clinical Trials

Author:

Cassetti Isabel¹,Madruga José Valdez R.²,Suleiman Jamal Muhamad A.H.³,Etzel Arnaldo⁴,Zhong Lijie⁵,Cheng Andrew K.⁵,Enejosa Jeffrey⁵,

Affiliation:

1. Fundacion Centro Estudios InfectologicosBuenos Aires, Argentina

2. Centro de Referência e Treinamento DST/AIDS, São Paulo, Brazil

3. Brasilmed Assistência Médica e Pesquisas, São Paulo, Brazil

4. Hospital Guilherme Álvaro Santos, Brazil

5. Gilead Sciences Foster City, California, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Infectious Diseases

Link

https://www.tandfonline.com/doi/pdf/10.1310/hct0803-164

Reference16 articles.

1. Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus Infection

2. US Department of Health and Human Services Panel on Clinical Practices for Treatment of HIV Infection. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents; October 10, 2006. Available at http://AIDSinfo.nih.gov.

3. Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized Trial

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Humeral Shaft Fracture Nonunion and HIV Pre-exposure Prophylaxis (PrEP): A Case Report;SurgiColl;2023-12-22

2. Bone turnover change after randomised switch from tenofovir disoproxil to tenofovir alafenamide fumarate in men with HIV;AIDS;2023-12-07

3. Tenofovir disoproxil fumarate versus tenofovir alafenamide on risk of osteoporotic fracture in patients with chronic hepatitis B: A nationwide claims study in South Korea;Alimentary Pharmacology & Therapeutics;2023-09-11

4. Bone mineral density among virologically suppressed Asians older than 50 years old living with and without HIV: A cross-sectional study;PLOS ONE;2022-11-21

5. Impact of weight-bearing and sex-stratified differences in risk factors of bone loss on bone mineral density in HIV conditions – findings of the Nigeria HIV-BMD study: An observational study;2022-10-14